Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Michael Seckl
Imperial College London - Departments of Medical Oncology
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
94
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Depth of Response to Primary Chemotherapy Predicts Survival in Poor Prognosis Germ-Cell Tumours
Number of pages: 26
Posted: 31 May 2023
Lara Ulrich (first author)
,
Anand Sharma
,
Sarah Howlett
,
Alice Maxwell
,
Dee Short
,
Ignacio Vazquez
,
Roshan Agarwal
,
David Hrouda
,
Ethna Mannion
,
Edmund Wilkes
,
Jingky Lozano-Kuehne
,
Gordon Rustin
,
Terry Tin
,
Naveed Sarwar
, Michael Seckl and
Ehsan Ghorani
Imperial College London - Departments of Medical Oncology, Mount Vernon Hospital - Department of Medical Oncology, Mount Vernon Hospital - Department of Medical Oncology, Mount Vernon Hospital - Department of Medical Oncology, Imperial College London - Departments of Medical Oncology, Mount Vernon Hospital - Department of Medical Oncology, Imperial College London - Departments of Medical Oncology, Imperial College London - Imperial Urology, Imperial College London - Department of Histopathology, Imperial College London - Department of Biochemistry, Imperial College London - Department of Surgery and Cancer, Mount Vernon Hospital - Department of Medical Oncology, Imperial College London - Departments of Medical Oncology, Imperial College London - Departments of Medical Oncology, Imperial College London - Departments of Medical Oncology and Imperial College London - Departments of Medical Oncology
Downloads
94
(720,278)
View PDF
Download
Abstract:
PRGCT, poor-risk, non-seminomatous, germ-cell cancer, depth of response, POMB/ACE, chemotherapy
Feedback